03 May 2026
Importing Medical Cannabis to the UK: A Regulatory Guide
The Legal Framework for Cannabis Imports Medical cannabis imports require a controlled drug import licence from the Home Office Each consignment typically…
Read More →Medical Cannabis UK — Blog & Patient Guides
Expert information on medical cannabis prescriptions, conditions, strains and patient experiences in the United Kingdom.
02 May 2026
Cannabis Rescheduling: History and Current Status in the UK
From Prohibition to Prescription: The Journey to Rescheduling Cannabis was originally placed in Schedule 1 in 1971, preventing any medical use Advisory…
Read More →
02 May 2026
MHRA and Medical Cannabis Licensing in the UK
The MHRA’s Role in Regulating Cannabis-Based Medicines The MHRA is responsible for licensing medicinal products in the UK including cannabis-based medicines Full…
Read More →
01 May 2026
Schedule 2 Controlled Drugs: What Prescribers Need to Know
Understanding the Controlled Drug Prescription Requirements Prescriptions for Schedule 2 drugs must be handwritten or generated by an approved system The prescription…
Read More →
01 May 2026
Medical Cannabis and the Misuse of Drugs Act 1971
The Legal Framework for Controlled Substances in the UK The Misuse of Drugs Act 1971 classifies cannabis as a Class B controlled…
Read More →
29 Apr 2026
Private Medical Cannabis vs NHS: Differences Explained
The NHS and Medical Cannabis: The Reality The NHS can prescribe cannabis-based medicines but does so extremely rarely in practice NICE guidelines…
Read More →
26 Apr 2026
Sapphire Medical vs Releaf vs Alternaleaf: Which Clinic?
Overview of the UK’s Leading Private Cannabis Clinics Sapphire Medical Foundations: one of the UK’s longest-established cannabis clinics, research-focused, operates the UK…
Read More →
20 Apr 2026
Cannabis and Safeguarding: Prescribing Safely for Vulnerable Patients
Safeguarding Obligations in Cannabis Prescribing UK law and GMC guidance require prescribers to consider safeguarding in all clinical interactions Vulnerable adults and…
Read More →
19 Apr 2026
Adverse Event Reporting for Cannabis Prescribers in the UK
The UK Yellow Card Scheme and Cannabis The MHRA Yellow Card Scheme is the UK’s national pharmacovigilance system for reporting adverse drug…
Read More →
19 Apr 2026
Patient Monitoring and Follow-Up Protocol for Cannabis Prescribers
Why Structured Follow-Up Is Non-Negotiable in Cannabis Prescribing Cannabis is a Schedule 2 controlled drug — prescribers carry enhanced duty of care…
Read More →